SCHEMBL672008

SCHEMBL672008

Cc1ccc(NC(=O)N2CCCC2)cc1NC(=O)N1CCCC1

nearest known ligand 0.75

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.75
NPC1 O15118 5/20 0.75
L3MBTL1 Q9Y468 2/20 0.73
HTT P42858 1/20 0.73
ALDH1A1 P00352 3/20 0.61
KDM4E B2RXH2 1/20 0.58
GLA P06280 1/20 0.58
GAA P10253 1/20 0.58
HPGD P15428 1/20 0.58
KLK7 P49862 1/20 0.58
KMT2A Q03164 3/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
MEN1 O00255 2/20 0.58
MAPT P10636 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1610477 0.94 RAB9A (0.65) RAB9ANPC1L3MBTL1HTTALDH1A1
SCHEMBL17346760 0.86 RAB9A (0.78) RAB9ANPC1L3MBTL1HTTALDH1A1
SCHEMBL4559342 0.84 RAB9A (0.91) RAB9ANPC1L3MBTL1HTTALDH1A1
SCHEMBL25668726 0.83 RAB9A (0.73) RAB9ANPC1L3MBTL1HTTALDH1A1
SCHEMBL9283129 0.81 RAB9A (0.65) RAB9ANPC1L3MBTL1HTTALDH1A1
SCHEMBL19180399 0.80 RAB9A (0.73) RAB9ANPC1L3MBTL1HTTALDH1A1
SCHEMBL15386823 0.79 ITGB1 (0.54) RAB9ANPC1L3MBTL1HTTALDH1A1
SCHEMBL18334215 0.79 RAB9A (0.70) RAB9ANPC1L3MBTL1HTTALDH1A1
SCHEMBL6037506 0.78 RAB9A (0.96) RAB9ANPC1L3MBTL1HTTALDH1A1
SCHEMBL25668730 0.78 RAB9A (0.71) RAB9ANPC1L3MBTL1HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12590228-B2 Curable adhesive composition for die attach HENKEL AG & CO. KGAA (DE) 2026-03-31 US disclosed
US-20210062047-A1 CURABLE ADHESIVE COMPOSITION FOR DIE ATTACH HENKEL AG & CO KGAA (DE) 2021-03-04 US disclosed
EP-2297262-B1 SILVER COATED FLAKY MATERIAL FILLED CONDUCTIVE CURABLE COMPOSITION AND THE APPLICATION IN DIE ATTACH Henkel IP & Holding GmbH (DE) 2016-12-21 EP disclosed
WO-2014026910-A1 CURABLE COMPOSITIONS COMPRISING COMPOSITE PARTICLES HENKEL AG & CO. KGAA (DE) 2014-02-20 WO disclosed
WO-2012022011-A1 STABILIZED, SILVER COATED FILLER-CONTAINING CURABLE COMPOSITIONS ABLESTIK (SHANGHAI) LIMITED (CN) 2012-02-23 WO disclosed
EP-1707585-B1 ONE-COMPONENT EPOXY RESIN COMPOSITION AJINOMOTO KK (JP) 2011-09-28 EP disclosed
US-20110095241-A1 SILVER COATED FLAKY MATERIAL FILLED CONDUCTIVE CURABLE COMPOSITION AND THE APPLICATION IN DIE ATTACH KONG HAO 2011-04-28 US disclosed
EP-2297262-A1 SILVER COATED FLAKY MATERIAL FILLED CONDUCTIVE CURABLE COMPOSITION AND THE APPLICATION IN DIE ATTACH Henkel Corporation (US) 2011-03-23 EP disclosed
WO-2010000096-A1 SILVER COATED FLAKY MATERIAL FILLED CONDUCTIVE CURABLE COMPOSITION AND THE APPLICATION IN DIE ATTACH NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING COPORATION (US) 2010-01-07 WO disclosed
WO-2009082833-A1 FUNCTIONAL FLUORIDE ANTI-BLEED AGENTS WITH REACTIVE GROUPS AN APPLICATION IN ORGANIC BASED CURABLE COMPOSITIONS HENKEL AG & CO. KGAA (DE) 2009-07-09 WO disclosed
US-7479534-B2 One-component epoxy resin composition AJINOMOTO CO., INC. (JP) 2009-01-20 US disclosed
US-20070021582-A1 Mixing epoxy resin having 2 or more epoxy groups, a polythiol, a compound that releases a basic component under a curing temperature condition and dissolves in polythiol such as an amineimide, a urea, or an isocyanate; and a Lewis acid; heating, curing; storage stability AJINOMOTO CO., INC. (JP) 2007-01-25 US disclosed
EP-1707585-A1 ONE-COMPONENT EPOXY RESIN COMPOSITION Ajinomoto Co., Inc. (JP) 2006-10-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12590228-B2 Curable adhesive composition for die attach AS3MT, BMI1, VIM RAB9A 2643/4885NPC1 4443/4885L3MBTL1 182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.